RSS 0343
Alternative Names: RSS-0343Latest Information Update: 12 Jan 2024
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Bronchiectasis
Most Recent Events
- 05 Dec 2023 Phase-I clinical trials in Bronchiectasis (unspecified route), prior to December 2023 (Jiangsu Hengrui Medicine pipeline, December 2023)